HeartTrends Heart Rate Variability (HRV) Algorithm for the Diagnosis of Myocardial Ischemia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

450 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-08-31

Study Completion Date

2014-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators intend to prospectively enroll consecutive patients, without known ischemic heart disease, referred by their physician for routine exercise MPI at a tertiary care center.

Prior to the MPI (nuclear stress test), eligible and consenting patients will undergo a one-hour period of Holter ECG digital recording. Application of ECG electrodes will be performed by medical technicians following standard recommendations, utilizing approved Holter device \& stickers. The Holter ECG data will be used for the offline heart rate variability (HRV) analysis by the HeartTrends device.

Immediately following data acquisition, all patients will undergo an exercise MPI according to accepted clinical practice guidelines.

Following the MPI, there will be no interference with patient management, which will be conducted by the patients' treating physicians according to current guidelines, unaware of HRV results.

Analysis of recorded ECG data for HRV will be performed blinded to the EST and MPI results, by HeartTrends device.

The results of the HRV tests will not be available to treating physicians and will not be used to guide patient management. Patients will be followed for 6 months for the occurrence of coronary interventions and MACE, defined as: death, myocardial infarction, unstable angina, or any coronary revascularization.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

HeartTrends HRV Algorithm for the Detection of Myocardial Ischemia

NCT02201017

Heart Rate Variability Ischemia Detection

UNKNOWN

Heart Rate Variability (HRV) Testing Compared With Exercise Stress Test in Hospitalized Patients With Chest Pain

NCT02530021

Angina Pectoris Ischemic Heart Disease

UNKNOWN

Heart Rate Variability as a Predictor of Ischemic Heart Disease

NCT02959788

Acute Coronary Syndrome

COMPLETED

Evaluating Microvascular Dysfunction in Symptomatic Patients With HypertroPhic CaRdiomyopathy

NCT02994615

Hypertrophic Cardiomyopathy

COMPLETED

Analysis of Heart Muscle Function Following Exercise in Patients With Heart Disease

NCT00001528

Healthy

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ischemic Heart Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 21
* Referral for exercise MPI by treating physicians
* Willing and able to provide written informed consent

Exclusion Criteria

* Established ischemic heart disease
* Atrial fibrillation or flutter
* Acute Coronary Syndrome
* Cardiac Pacemaker
* Clinical diagnosis of heart failure
* Moderate or severe COPD
* Active myocarditis, constrictive pericarditis, any cardiomyopathy, cardiac or systemic amyloidosis
* Known drug or alcohol dependence or any other factors which will interfere with the study conduct or interpretation of the results or in the opinion of the investigator are not suitable to participate;
* Any illness that might reduce life expectancy to less than 1 year from screening
* Left bundle branch block (LBBB), significant intra-ventricular conduction delay (IVCD) or significant (\>1mm) ST deviations on baseline ECG
* Inability to perform an exercise stress test (i.e. orthopedical or neurological limitations)
* Any significant established myocardial or valvular disease

Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No